Category: Operations and supply chain management
The shift toward advanced therapeutic modalities will require life sciences companies to rethink strategy, investments, and risk management.
New research suggests that consumers value a product more highly when its manufacturers take responsibility for its disposal.
There are downsides to pursuing efficiency at all costs.
If you’re making complex strategic decisions based off of big, emerging trends in your industry, this episode is for you.
And what companies can do about it.
When they do, a mutually beneficial outcome is more likely.